Psychiatric Neurosciences
The Division of Psychiatric Neurosciences is composed of researchers at the University of Washington Medical Center, Harborview Medical Center, Veterans Affairs Puget Sound Health Care System, and Seattle Children's. Its primary goal is to develop the Department of Psychiatry and Behavioral Sciences' research and research training in basic and clinical neurosciences. Based on the research interests of faculty members, the Division is subdivided into the areas of Behavioral Genetics, Molecular and Cellular neurosciences, Clinical and Developmental neurosciences, Neuroimaging, and Psychopharmocology. Research within the Division is directed toward understanding psychiatric disturbances and normal and abnormal behaviors at a fundamental biological level, along with the mechanism of action and/or development of drugs useful in the treatment of psychiatric diseases.
| Behavioral Genetics | ||
| Zoran Brkanac, M.D. | Molecular Genetics of Ataxia and Reading Disability | |
| Parvoneh Poorkaj Navas, Ph.D. | Molecular and Genetic Interactions in Tauopathies | |
| Wendy Raskind, M.D. | Developmental and Molecular Genetics | |
| Debby Tsuang, M.D., M.Sc. | Genetic Epidemiology of Dementia and Schizophrenia | |
| Clinical Neuroscience | ||
| David Avery M.D. | Neurobiology and Treatment of Affective | |
| Monique Cherrier, Ph.D. | Aging, Alzheimer's Disease, Memory, Neuroimaging | |
| Suzanne Craft, Ph.D. | Neuroendocrine Effects on Cognitive Function in Normal and Pathological Aging | |
| Elaine R. Peskind, M.D. | Stress Hormones in Aging and Alzheimer's Disease | |
| Allen Radant, M.D. | Oculomotor Dysfunction in Schizophrenia/Genetics of Schizophrenia | |
| Murray Raskind, M.D. | Neuroendocrinology and Treatment of Alzheimer's Disease | |
| Peter Roy-Byrne, M.D. | Genetic Markers of Treatment Response | |
| Richard Veith, M.D. | Major Depression in Cardiac Disease, Sympathetic Nervous System Function | |
| Peter Vitaliano, Ph.D. | Interface of Chronic Stress, Psychophysiology and Cognition | |
| Michael V. Vitiello, Ph.D. | The Effects of Aging on Sleep | |
| Clinical Psychopharmacocogy /Toxicology |
||
| Andre' M. Tapp M.D. | Psychopharmacology of Schizophrenia | |
| Developmental Neuroscience | ||
| Ann Streissguth, Ph.D. | Brain Impairment Associated with Prenatal Alcohol Exposure | |
| Enrique Villacres M.D. | Genetic Causes of Autism | |
| Sara Webb Ph.D. | Developmental Cognitive Neuroscience, Neurobiology of Autism | |
| Molecular & Cellular Neuroscience | ||
| Douglas Bowden M.D. | Primate Behavior and Neurobiology | |
| Michael Clark, M.D., Ph.D. | The Molecular Biology of Stress and the Dorsal Raphe | |
| Mark Dubach M.D. | Basal Ganglia Neurophysiology | |
| Ruth Kohen M.D. | Serotonin Receptors, Molecular Basis of Mood Disorders and Schizophrenia | |
| Dianne Lattemann Ph.D. | Endocrinology, Insulin Metabolism & Action, Brain-Gut Peptides | |
| James Leverenz M.D. | Molecular Pathology of the Locus Coeruleus | |
| Pamela McMillan, Ph.D. | Insulin and glucocorticoid pathways in neurodegenerative diseases | |
| John Neumaier, M.D., Ph.D. | Serotonin receptors in animal models of stress, addiction, and cognition/Neuroendocrine regulation of serotonin neurotransmission/Molecular pharmacology of serotonin receptors | |
| Valerie Olson, Ph.D. | Norepinephrine in animal models of post-traumatic stress disorder and addiction | |
| Paul Phillips, Ph.D. | Neurochemistry and Behavior | |
| Dennis Rasmussen, Ph.D. | Neuroendocrine Mechanisms in Alcohol Abuse | |
| Nephi Stella, Ph.D. | Cannabinoids as Therapy for Brain Tumors | |
| Patricia Szot, Ph.D. | Regulation of Monoamine Transporters | |
| Charles Wilkinson, Ph.D. | Neuroendocrine Function in Aging and Alzheimer's Disease | |
| Neuroimaging | ||
| Elizabeth Aylward, Ph.D. | Structural and Functional MRI | |
| Paul Borghesani, M.D., Ph.D. | Neuroimaging of aging and dementia | |
| Paul Connor, Ph.D. | Neuropsychological and Neuroimaging Assessment of the Effects of Prenatal Alcohol Exposure | |
| Satoshi Minoshima, M.D., Ph.D. | Neurodegenerative Diseases and Other Brain Disorders Using Innovative Imaging Technology | |
| Eric C. Petrie, M.D. | Structural and Functional Neuroimaging of Cholinergic and Adrenergic Function in Neurodegenerative and Psychiatric Disorders | |
